Discovery of VHR phosphatase inhibitors with micromolar activity based on structure-based virtual screening

被引：10

作者：

Park, Hwangseo ^{[1
]}

Jung, Suk-Kyeong ^{[2
]}

Jeong, Dae Gwin ^{[3
]}

Ryu, Seong Eon ^{[3
]}

Kim, Seung Jun ^{[2
]}

机构：

[1] Sejong Univ, Dept Biosci & Biotechnol, Seoul 143747, South Korea

[2] Korea Res Inst Biosci & Biotechnol, Translat Res Ctr, Taejon 305333, South Korea

[3] Korea Res Inst Biosci & Biotechnol, Syst Prote Res Ctr, Taejon 305333, South Korea

来源：

CHEMMEDCHEM | 2008年 / 3卷 / 06期

关键词：

docking; inhibitors; solvation; VHR phosphatase; virtual screening;

D O I：

10.1002/cmdc.200700348

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

(Chemical Equation Presented) Human VHR phosphatase has been shown to be involved in the regulation of cell-cycle progression and is itself modulated during the cell cycle, indicating that VHR can serve as a therapeutic target for cancer. In the present study, we identify new VHR inhibitors by means of a structure-based drug design protocol involving the virtual screening with docking simulations and in vitro enzyme assay. © 2008 Wiley-VCH Verlag GmbH & Co. KGaA.

引用

页码：877 / 880

页数：4

共 50 条

[21] Discovery of novel choline acetyltransferase inhibitors using structure-based virtual screening
Rajnish Kumar
Amit Kumar
Bengt Långström
Taher Darreh-Shori
Scientific Reports, 7
[22] Structure-Based Virtual Screening of Protein Tyrosine Phosphatase Inhibitors: Significance, Challenges, and Solutions
Reddy, Rallabandi Harikrishna
Kim, Hackyoung
Cha, Seungbin
Lee, Bongsoo
Kim, Young Jun
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2017, 27 (05) : 878 - 895
[23] Discovery of Novel HPK1 Inhibitors Through Structure-Based Virtual Screening
Ge, Huizhen
Peng, Lizeng
Sun, Zhou
Liu, Huanxiang
Shen, Yulin
Yao, Xiaojun
FRONTIERS IN PHARMACOLOGY, 2022, 13
[24] Discovery of new potent inhibitors for carbonic anhydrase IX by structure-based virtual screening
Wang, Liyan
Yang, Chunmei
Lu, Weiqiang
Liu, Li
Gao, Rui
Liao, Sha
Zhao, Zhenjiang
Zhu, Lili
Xu, Yufang
Li, Honglin
Huang, Jin
Zhu, Weiping
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (12) : 3496 - 3499
[25] Discovery of non-peptide inhibitors of Plasmepsin II by structure-based virtual screening
Song, Yuwei
Jin, Huangtao
Liu, Xiaofeng
Zhu, Lili
Huang, Jin
Li, Honglin
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (07) : 2078 - 2082
[26] Discovery of Novel Neuraminidase Inhibitors by Structure-Based Virtual Screening, Structural Optimization, and Bioassay
Yu, Rao
Cheng, Li Ping
Li, Meng
Pang, Wan
ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (12): : 1667 - 1673
[27] Discovery of new Schistosoma mansoni aspartyl protease inhibitors by structure-based virtual screening
Gomes, Barbara Figueira
Senger, Mario Roberto
Moreira-Filho, Jose Teofilo
de Vasconcellos Junior, Fabio Jorge
Dantas, Rafael Ferreira
Owens, Raymond
Andrade, Carolina Horta
Neves, Bruno Junior
Silva-Junior, Floriano Paes
MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2023, 118
[28] Structure-based virtual screening for the discovery of natural inhibitors for human rhinovirus coat protein
Rollinger, Judith M.
Steindl, Theodora M.
Schuster, Daniela
Kirchmair, Johannes
Anrain, Kathrin
Ellmerer, Ernst P.
Langer, Thierry
Stuppner, Hermann
Wutzler, Peter
Schmidtke, Michaela
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (04) : 842 - 851
[29] Discovery of new GSK-3β inhibitors through structure-based virtual screening
Dou, Xiaodong
Jiang, Lan
Wang, Yanxing
Jin, Hongwei
Liu, Zhenming
Zhang, Liangren
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (02) : 160 - 166
[30] Discovery of human TyrRS inhibitors by structure-based virtual screening, structural optimization, and bioassays
Huang, Shenzhen
Wang, Xiang
Lin, Guifeng
Cheng, Jie
Chen, Xiuli
Sun, Weining
Xiang, Rong
Yu, Yamei
Li, Linli
Yang, Shengyong
RSC ADVANCES, 2019, 9 (16): : 9323 - 9330

← 1 2 3 4 5 →